Search
Novartis AG
NVSAdd to Watchlist
140.980USD
+0.610+0.43%
Close 09-21 16:00（ET）
267.94BMarket Cap
20.06P/E TTM
After-hours 18:30 (ET)140.980USD-0.180-0.13%
After-hours 18:30 (ET)Novartis AG (NVS) Stock Price Target & Forecast
Analyst Rating
Based on 10 analysts giving stock ratings to Novartis AG in the past month.
Hold
1 Strong Buy
2 Buy
4 Hold
3 Sell
0 Strong Sell
Target Price
152.570USD+8.69%
NVS Analyst Recommendation Trends
In the current month, NVS has received 2 Buy Ratings, 4 Hold Ratings, and 3 Sell Ratings. NVS average Analyst price target in the last month is 152.570.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
1
1
1
1
1
1
1
1
2
2
2
2
2
2
1
0
4
4
4
4
4
4
4
5
0
0
0
0
0
0
0
0
3
3
3
3
3
3
3
3
10
10
10
10
10
10
9
9
NVS Analyst Rating for Peer Comparison
Updated: Sep 21, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Amgen Inc
AMGN
4
12
18
2
1
37
Biogen Inc
BIIB
7
17
12
1
0
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Regeneron Pharmaceuticals Inc
REGN
6
15
11
0
0
32
Merck & Co Inc
MRK
8
14
10
0
0
32
Pfizer Inc
PFE
5
6
19
1
1
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Financial Forecasting
Based on analysts' estimates, NVS EPS is projected to reach 2.285 in FY2026Q3, following reported EPS of 1.713 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
1.99
2.08
2.36
2.28
2.19
Actual
1.26
1.65
1.71
--
--
Surprise
-36.81%
-20.71%
-27.34%
--
--
FAQs
What is Novartis AG's expected revenue for the next quarter?
Novartis AG's expected revenue is 14.49B.
What is Novartis AG's price target?
Analysts forecast that Novartis AG's price target is USD 152.57, with the highest forecast at USD 185.00 and the lowest forecast at USD 116.00.
How have Novartis AGNVS's recent earnings per share performed?
The market expectation was USD 1.71, while Novartis AGNVS's earnings per share (EPS) for the previous quarter was USD 1.65. EPS for the next quarter is expected at USD 2.28.
What is the analyst rating for Novartis AG?
Based on the ratings of Novartis AG's stock from 10 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.